The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.
David R. Liu, a biologist at the Broad Institute and Harvard, is the lead author of a new study of a gene-editing strategy that could be standardized for multiple people with rare diseases.
An advocate for women’s reproductive health, she started one of the world’s smallest pharmaceutical companies to bring an emergency birth-control method to market.
Sharon Camp in 2000. One of the many obstacles to bringing the morning-after pill to the United States, she said, was the pharmaceutical industry, which “demonstrated the political instincts of celery.”
Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency reeling under staff cuts and low morale.
Dr. Richard Pazdur will now lead the Center for Drug Evaluation and Research, which is in charge of regulating most prescription drugs and over-the-counter medicines.
Merck, which first introduced statins to the world nearly 40 years ago, announced that its new pill helped reduce heart attack and stroke rates in high risk patients by 20 percent in a year.
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
Dr. Reddy’s, an Indian generic drugmaker, in March closed its factory in Shreveport, La.
The official, Dr. George Tidmarsh, has become embroiled in an ethical dispute and is now the target of a lawsuit over his actions involving certain drugs tied to a business associate.
Login
